SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-046767
Filing Date
2019-10-01
Accepted
2019-10-01 16:32:53
Documents
13
Period of Report
2019-10-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv530272_8k.htm   iXBRL 8-K 34033
2 EXHIBIT 10.1 tv530272_ex10-1.htm EX-10.1 62259
  Complete submission text file 0001144204-19-046767.txt   282780

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA srne-20191001.xsd EX-101.SCH 3223
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE srne-20191001_lab.xml EX-101.LAB 33476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srne-20191001_pre.xml EX-101.PRE 21983
14 EXTRACTED XBRL INSTANCE DOCUMENT tv530272_8k_htm.xml XML 3490
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36150 | Film No.: 191129533
SIC: 8731 Services-Commercial Physical & Biological Research